Psychotropic medications and the transition into care: A national data linkage study

Journal of the American Geriatrics Society

Volumn 61, Issue 2, 2013, Pages 215-221

  Maguire, Aideen ^a   Hughes, Carmel ^a   Cardwell, Chris ^a   O'Reilly, Dermot ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

care homes; drug safety; older people; pharmacoepidemiology; record linkage

Indexed keywords

ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; HYPNOTIC AGENT; PSYCHOTROPIC AGENT;

AGED; ARTICLE; CROSS-SECTIONAL STUDY; DATA BASE; DRUG USE; GROUP THERAPY; HUMAN; MEDICAL INFORMATION; NURSING HOME; UNITED KINGDOM;

AGED; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DEMENTIA; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HUMANS; MALE; NORTHERN IRELAND; PSYCHOTROPIC DRUGS; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 84873986165     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12101     Document Type: Article

References (39)

1. Stafford N,. At least 25% of elderly residents of German nursing homes are addicted to psychotropic drugs, report claims. BMJ 2010; 340: c2029.
2. Oborne AC, Hooper R, Li KC, et al. An indicator of appropriate neuroleptic prescribing in nursing homes. Age Ageing 2002; 31: 435-439.
3. Mann E, Köpke S, Haastert B, et al. Psychotropic medication use among nursing home residents in Austria: A cross-sectional study. BMC Geriatr 2009; 9: 18-25.
4. Feng Z, Hirdes JP, Smith TF, et al. Use of physical restraints and antipsychotic medications in nursing homes: A cross-national study. Int J Geriatr Psychiatry 2009; 24: 1110-1118.
5. In Defence of Dignity-The Human Rights of Older People in Nursing Homes. March 2012. Northern Ireland Human Rights Commission. ISBN 1903681863.
6. Banerjee S,. The Use of Antipsychotic Medication for People with Dementia: Time for Action. London: Department of Health, 2009.
7. Ballard C, Margallo-Lana M, Juszczak E, et al. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: Randomised double blind placebo controlled trial. BMJ 2005; 330: 874.
8. Rosenberg PB, Mielke MM, Han D, et al. The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. Int J Geriatr Psychiatry 2012; 27: 1248-1257.
9. Huybrechts KF, Gerhard T, Crystal S, et al. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: Population based cohort study. BMJ 2012; 344: e977.
10. Stoudemire A, Smith DA,. OBRA regulations and the use of psychotropic drugs in long term care facilities. Impact and implications for geropsychiatric care. Gen Hosp Psych 1996; 18: 77-94.
11. Azermai M, Petrovic M, Elseviers MM, et al. Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms. Ageing Res Rev 2012; 11: 78-86.
12. National Institute for Health Clinical Excellence. Social Care Institute for Excellence. A NICE-SCIE Guideline on supporting people with dementia and their carers in health and social care. London: The British Psychological Society and Gaskell, 2007.
13. Chen Y, Briesacher B, Field T, et al. Unexplained variation across U.S. nursing homes in antipsychotic prescribing rates. Arch Intern Med 2010; 170: 89-95.
14. Rochon PA, Stukel TA, Bronskill SE, et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med 2007; 167: 676-683.
15. Kales HC, Zivin K, Kim HM, et al. Trends in antipsychotic use in dementia 1999-2007. Arch Gen Psychiatry 2011; 68: 190-198.
16. Guthrie B, Clark S,. Time Trends in Psychoactive Prescribing to People with Dementia in Scotland 2001-2011. Dundee, Scotland: University of Dundee & NHS Fife, 2012.
17. Hughes CM, Lapane KL, Watson MC, et al. Does organisational culture influence prescribing in care homes for older people? A new direction for research. Drugs Aging 2007; 24: 81-93.
18. Shah S, Carey I, Harris T, et al. Antipsychotic prescribing to older people living in care homes and the community in England and Wales. Int J Geriatr Psychiatry 2011; 26: 423-423.
19. McGavock H, Wilson-Davis K, Connolly JP,. Repeat prescribing management-a cause for concern? Brit J Gen Pract 1999; 49: 343-347.
20. British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary 62. London: BMJ Group & RPS Publishing, 2011.
21. Gallagher P, O'Mahoney D,. STOPP (Screening Tool for Older Person's potentially inappropriate Prescriptions): Application to acutely ill elderly patients and comparison with Beer's criteria. Age Ageing 2008; 37: 673-679.
22. Bradley MC, Fahey T, Cahir C, et al. Potentially inappropriate prescribing and cost outcomes for older people: A cross sectional study using the Northern Ireland Enhanced Prescribing Database. Eur J Clin Pharmacol 2012; 68: 1425-1433.
23. McCann M, O'Reilly D, Cardwell C,. A census-based longitudinal study of variations in survival amongst residents of nursing and residential homes in Northern Ireland. Age Ageing 2009; 38: 711-717.
24. McCann M, Donnelly M, O'Reilly D,. Living arrangements, relationship to people in the household and risk of admission to care homes for older people. Age Ageing 2011; 40: 358-363.
25. McCann M, Grundy E, O'Reilly D,. Why is housing tenure associated with a lower risk of admission to a nursing or residential home? Wealth, health and the incentive to keep 'my home'. J Epidemiol Community Health 2012; 66: 166169.
26. Barr P, Shuttleworth I,. Reporting address changes by migrants: The accuracy and timeliness of reports via health card registers. Health Place 2012; 18: 595-604.
27. Altman DG, Bland JM,. Interaction revisited: The difference between two estimates. BMJ 2003; 326: 219.
28. Kamble P, Chen H, Shere J, et al. Antipsychotic drug use among elderly nursing home residents in the United States. Am J Geriatr Pharmacother 2008; 614: 187-197.
29. O'Connor DW, Griffith J, McSweeney K,. Change to psychotropic medications in the six months after admission to nursing homes in Melbourne, Australia. Int Psychogeriatr 2010; 22: 1149-1153.
30. Cohen-Mansfield J, Lipson S, Gruber-Baldini AL, et al. Longitudinal prescribing patterns of psychotropic drugs in nursing home residents. Exp Clin Psychopharmacol 1996; 4: 224-233.
31. Zuidema SU, De Jonghe JFM, Verhey FRJ, et al. Psychotropic drug prescription in nursing home patients with dementia: Influence of environmental correlates and staff distress on physicians' prescription behaviour. Int Psychogeriatr 2011; 23: 10.
32. McCleery J, Fox R,. Antipsychotic prescribing in nursing homes. We need to understand why this practice continues despite the mortality risk. BMJ 2012; 344: e1093.
33. Levinson DR,. Medicare Atypical Antipsychotic Drug Claims for Elderly Nursing Home Residents (OEI-07-08-00150). Washington, DC: Department of Health and Human Services, Office of Inspector General, 2011.
34. Lakey L,. Counting the Cost: Caring for People with Dementia on Hospital Wards. Enfield, UK: FiSH Books, 2009.
35. Health and Social Care in Northern Ireland. Advice on Clinical Use of Antipsychotic Drugs [on-line]. Available at http://www.hscboard.hscni.net/ medicinesmanagement/Prescribing%20Guidance/Antipsychotics/index.html Accessed August 23, 2012.
36. Yourman L, Concato J, Agostini JV,. Use of computer decision support interventions to improve medication prescribing in older adults: A systematic review. Am J Geriatr Pharmacother 2008; 6: 119-129.
37. Schweizer AK, Hughes CM,. Nursing and residential care for the elderly in Northern Ireland: The contribution of the pharmacist. Pharm World Sci 2001; 23: 195-199.
38. Patterson SM, Hughes CM, Crealey GC, et al. An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland Study). J Am Geriatr Soc 2010; 58: 44-53.
39. O'Mahoney D, Gallagher P, Ryan C, et al. STOPP & START criteria: A new approach to detecting potentially inappropriate prescribing in old age. Eur Geriatr Med. 2010; 1: 45-51.